Argent Biopharma Limited has released a press release.
Placing to Raise US$4,500,000
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Trading Halt
- ASX Listing Update
- Placing to Raise A$200,000
- Preliminary Final Report
- Voluntary Delisting from ASX
Later from Argent Biopharma
- Corporate Update - Board Change
- Half Year Accounts
- Strategic Manufacturing Partnership with ECCPharm Limited
- Exclusive Agreement for Malta Manufacturing Facility
- Argent BioPharma Expands Pipeline with Promising Drug CimetrA®
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma